Literature DB >> 16842087

Global genetic variation of HIV-1 infection.

Cleo G Anastassopoulou1, Leondios G Kostrikis.   

Abstract

Variability, both at the population (interhost) as well as at the individual (intrahost) level is a key property of HIV that stems mainly from the inherent infidelity of the reverse transcriptase enzyme that the virus uses to transcribe its RNA genome into DNA so that it may be integrated into the human genetic material and propagated along with it. The lack of proofreading mechanisms, high turnover of virions, and propensity for recombination also contribute to the extensive variability of HIV. These parameters provide the virus quasispecies with an impressive capacity to adapt to immunologic, pharmacologic or other selection pressures and have important implications for the diagnosis of new infections, the monitoring of antiretroviral treatment response, and effective vaccine(s) design. Herein, we discuss in detail the global genetic variation of HIV-1 infection.

Entities:  

Mesh:

Year:  2006        PMID: 16842087     DOI: 10.2174/157016206777709456

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  7 in total

1.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

2.  Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.

Authors:  Leen Delang; Inge Vliegen; Mathy Froeyen; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

3.  Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

4.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

5.  Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.

Authors:  Georges Teto; Julius Y Fonsah; Claude T Tagny; Dora Mbanya; Emilienne Nchindap; Leopoldine Kenmogne; Joseph Fokam; Dora M Njamnshi; Charles Kouanfack; Alfred K Njamnshi; Georgette D Kanmogne
Journal:  Viruses       Date:  2016-07-18       Impact factor: 5.048

6.  Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

7.  Targeted resequencing of HIV variants by microarray thermodynamics.

Authors:  Wahyu W Hadiwikarta; Bieke Van Dorst; Karen Hollanders; Lieven Stuyver; Enrico Carlon; Jef Hooyberghs
Journal:  Nucleic Acids Res       Date:  2013-08-08       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.